No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes

Atherosclerosis

Volumn 177, Issue 2, 2004, Pages 415-422

  Damgaard, Dorte ^a   Jensen, Jesper Moeller ^a   Larsen, Mogens Lytken ^a   Soerensen, Vibeke Reiche ^a   Jensen, Henrik Kjaerulf ^a   Gregersen, Niels ^a   Jensen, Lillian Gryesten ^a   Faergeman, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ARH; CYP7A1; Familial hypercholesterolemia; Genetic linkage; Hypercholesterolemia; PCSK9; Third FH locus

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RECEPTORS, LDL; SERINE ENDOPEPTIDASES;

EID: 8644235087     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.028     Document Type: Article

References (40)

1. J.L. Goldstein, H.H. Hobbs, and M.S. Brown Familial Hypercholesterolaemia C.R. Scriver A.L. Beaudet W.S. Sly D. Vale The metabolic and molecular basis of inherited disease vol. III 2001 McGraw-Hill New York 2863 2914
2. L.F. Soria, E.H. Ludwig, and H.R. Clarke Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 Proc. Natl. Acad. Sci. USA 86 1989 587 591
3. D. Gaffney, J.M. Reid, and I.M. Cameron Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia Arterioscler. Thromb. Vasc. Biol. 15 1995 1025 1029
4. H.K. Jensen, L.G. Jensen, and H. Meinertz Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia Atherosclerosis 146 1999 337 344
5. S.W. Fouchier, J.C. Defesche, M.W. Umans-Eckenhausen, and J.P. Kastelein The molecular basis of familial hypercholesterolemia in The Netherlands Hum. Genet. 109 2001 602 615
6. K.E. Heath, S.E. Humphries, H. Middleton-Price, and M. Boxer A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom Eur. J. Hum. Genet. 9 2001 244 252
7. M. Varret, J.P. Rabes, and B. Saint-Jore A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32 Am. J. Hum. Genet. 64 1999 1378 1387
8. S.C. Hunt, P.N. Hopkins, and K. Bulka Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred Arterioscler. Thromb. Vasc. Biol. 20 2000 1089 1093
9. S. Canizales-Quinteros, C.A. Aguilar-Salinas, and E. Reyes-Rodriguez Locus on chromosome 6p linked to elevated HDL cholesterol serum levels and to protection against premature atherosclerosis in a kindred with familial hypercholesterolemia Circ. Res. 92 2003 569 576
10. M. Abifadel, M. Varret, and J.P. Rabes Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat. Genet. 34 2003 154 156
11. K.M. Timms, S. Wagner, and M.E. Samuels A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree Hum. Genet. 114 2004 349 353
12. N.G. Seidah, S. Benjannet, and L. Wickham The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation Proc. Natl. Acad. Sci. USA 100 2003 928 933
13. K.N. Maxwell, R.E. Soccio, E.M. Duncan, E. Sehayek, and J.L. Breslow Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice J. Lipid Res. 2003
14. K. Ouguerrram, M. Chetiveaux, and Y. Zair Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9 Arterioscler. Thromb. Vasc. Biol. 2004
15. C.K. Garcia, K. Wilund, and M. Arca Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein Science 292 2001 1394 1398
16. A.K. Soutar, R.P. Naoumova, and L.M. Traub Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 23 2003 1963 1970
17. C.R. Pullinger, C. Eng, and G. Salen Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype J. Clin. Invest. 110 2002 109 117
18. P. Couture, J.D. Otvos, and L.A. Cupples Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the framingham offspring study J. Lipid Res. 40 1999 1883 1889
19. S.K. Erickson, S.R. Lear, and S. Deane Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice J. Lipid Res. 44 2003 1001 1009
20. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
21. H.K. Jensen, L.G. Jensen, P.S. Hansen, O. Faergeman, and N. Gregersen High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing Clin. Chem. 42 1996 1140 1146
22. O.K. Rodningen, and T.P. Leren Application of long polymerase chain reaction in the study of the LDL receptor gene Scand. J. Clin. Lab. Invest. 56 1996 93 96
23. S.H. Kim, J.H. Bae, and J.J. Chae Long-distance PCR-based screening for large rearrangements of the LDL receptor gene in Korean patients with familial hypercholesterolemia Clin. Chem. 45 1999 1424 1430
24. J.P. Schouten, C.J. McElgunn, and R. Waaijer Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucl. Acids Res. 30 2002 e57
25. P.S. Hansen, N. Rudiger, A. Tybjaerg-Hansen, O. Faergeman, and N. Gregersen Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI J. Lipid. Res. 32 1991 1229 1233
26. C.R. Pullinger, L.K. Hennessy, and J.E. Chatterton Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity J. Clin. Invest. 95 1995 1225 1234
27. J. Boren, U. Ekstrom, B. Agren, P. Nilsson-Ehle, and T.L. Innerarity The molecular mechanism for the genetic disorder familial defective apolipoprotein B100 J. Biol. Chem. 276 2001 9214 9218
28. M. Bednarska-Makaruk, M. Bisko, and M.F. Pulawska Familial defective apolipoprotein B-100 in a group of hypercholesterolaemic patients in Poland. Identification of a new mutation Thr3492Ile in the apolipoprotein B gene Eur. J. Hum. Genet. 9 2001 836 842
29. D. Gaffney, C.R. Pullinger, and D.S. O'Reilly Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding Clin. Chim. Acta 321 2002 113 121
30. H. Al Kateb, S. Bahring, and K. Hoffmann Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia Circ. Res. 90 2002 951 958
31. G.M. Lathrop, J.M. Lalouel, C. Julier, and J. Ott Strategies for multilocus linkage analysis in humans Proc. Natl. Acad. Sci. USA 81 1984 3443 3446
32. L. Kruglyak, M.J. Daly, M.P. Reeve-Daly, and E.S. Lander Parametric and nonparametric linkage analysis: a unified multipoint approach Am. J. Hum. Genet. 58 1996 1347 1363
33. P. Schnohr, G. Jensen, P. Lange, H. Scharling, and M. Appleyard The Copenhagen city heart study. Tables with data from the third examination 1991-1994 Eur. Heart J. Suppl. 3 2001 1 83
34. A.H. ten Asbroek, P.J. de Mheen, J.C. Defesche, J.J. Kastelein, and L.J. Gunning-Schepers Results from a family and DNA based active identification programme for familial hypercholesterolaemia J. Epidemiol. Commun. Health 55 2001 500 502
35. J. Ott Analysis of Human Genetic Linkage. Revised edition 1991 The Johns Hopkins University Press Baltimore
36. P.S. Hansen Familial defective apolipoprotein B-100 Dan. Med. Bull. 45 1998 370 382
37. L.U. Gerdes, I.C. Klausen, I. Sihm, and O. Faergeman Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world Genet. Epidemiol. 9 1992 155 167
38. J. Wang, D.J. Freeman, and S.M. Grundy Linkage between cholesterol 7alpha-hydroxylase and high plasma low- density lipoprotein cholesterol concentrations J. Clin. Invest. 101 1998 1283 1291
39. S.N. Pimstone, X.M. Sun, and S.C. du Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada Arterioscler. Thromb. Vasc. Biol. 18 1998 309 315
40. E.J. Sijbrands, R.G. Westendorp, and J.C. Defesche Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study BMJ 322 2001 119 123